Predictive Value of Electromechanical Activation Time for In-Hospital Major Cardiac Adverse Events in Heart Failure Patients
المؤلفون المشاركون
Zhang, Jing
Liu, Wen-Xian
Lyu, Shu-Zheng
المصدر
العدد
المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-6، 6ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2020-01-03
دولة النشر
مصر
عدد الصفحات
6
التخصصات الرئيسية
الملخص EN
Objective.
This prospective study aimed to evaluate the value of the cardiac cycle time-corrected electromechanical activation time (EMATc) measured at admission for predicting major cardiac adverse events (MACEs) in hospitalized patients with chronic heart failure (CHF).
Methods.
CHF patients with a left ventricular ejection fraction (LVEF) lower than 50% N=145 were enrolled in this study.
Documented clinical end-points (MACEs) included cardiogenic death, onset of acute HF as assessed with invasive and noninvasive mechanical ventilation, and cardiogenic shock.
According to the different clinical end-points, patients were divided into two groups: a MACE group n=22 and a nonMACE group n=123.
EMATc, LVEF, and circulating levels of B type natriuretic peptide (BNP) and Troponin I (TnI) were measured.
Multivariate logistic regression analysis was used to examine the association between EMATc and MACEs.
The parameters adjusted in the multivariable model included EMATc, BNP, and heart rate.
The predictive value of EMATc was evaluated by receiver operating characteristic (ROC) curve analysis.
Results.
Elevated EMATc was an independent risk factor for MACEs (odds ratio [OR] 1.1443, 95% confidence interval [CI] 1.016–1.286, P=0.027).
The area under the ROC curve for EMATc was 0.799 (95% CI 0.702–0.896, P<0.001).
The optimal cutoff EMATc value was >13.8% with a sensitivity of 81.8% and a specificity of 65.9%.
Conclusions.
We demonstrated that an elevated EMATc measured at admission is an independent risk factor for MACEs among hospitalized CHF patients.
Acoustic cardiography measured at admission may provide a simple, noninvasive method for risk stratification of CHF patients.
This trial is registered with ChiCTR1900021470.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Zhang, Jing& Liu, Wen-Xian& Lyu, Shu-Zheng. 2020. Predictive Value of Electromechanical Activation Time for In-Hospital Major Cardiac Adverse Events in Heart Failure Patients. Cardiovascular Therapeutics،Vol. 2020, no. 2020, pp.1-6.
https://search.emarefa.net/detail/BIM-1138606
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Zhang, Jing…[et al.]. Predictive Value of Electromechanical Activation Time for In-Hospital Major Cardiac Adverse Events in Heart Failure Patients. Cardiovascular Therapeutics No. 2020 (2020), pp.1-6.
https://search.emarefa.net/detail/BIM-1138606
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Zhang, Jing& Liu, Wen-Xian& Lyu, Shu-Zheng. Predictive Value of Electromechanical Activation Time for In-Hospital Major Cardiac Adverse Events in Heart Failure Patients. Cardiovascular Therapeutics. 2020. Vol. 2020, no. 2020, pp.1-6.
https://search.emarefa.net/detail/BIM-1138606
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1138606
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر